| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/09/2007 | EP1781617A2 Alpha, beta-unsaturated esters and acids by stereoselective dehydration |
| 05/09/2007 | EP1781613A1 Piperidine derivatives as histamine h3 receptor ligands |
| 05/09/2007 | EP1781607A2 Pyrrolidine derivatives as muscarinic receptor antagonists |
| 05/09/2007 | EP1781288A2 Modulators of muscarinic receptors |
| 05/09/2007 | EP1572667B1 Cathepsin cysteine protease inhibitors and their use in the treatment of inflammation and immune disorders |
| 05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 05/09/2007 | EP1364959B1 Crystal of pyrimidine nucleoside derivative |
| 05/09/2007 | EP1238970B9 Cycloamine ccr5 receptor antagonists |
| 05/09/2007 | EP1191931B1 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 05/09/2007 | CN1960988A Compounds and compositions as protein kinase inhibitors |
| 05/09/2007 | CN1960983A Arylsulfonyl benzodioxanes useful for modulation the 5-HT6 receptor, the 5-HT2areceptor or both |
| 05/09/2007 | CN1960976A 4-carbox pyrazole derivates useful as anti-viral agents |
| 05/09/2007 | CN1960975A Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP) |
| 05/09/2007 | CN1960971A Substituted pyrrolidine-2-ones |
| 05/09/2007 | CN1960970A Pyrrolidine derivatives as CB1-receptor antagonists |
| 05/09/2007 | CN1960969A Histamine H3 receptor agents, preparation method and therapeutic uses thereof |
| 05/09/2007 | CN1314681C 2,3-diazanaphthalene derivatives with angiogenesis inhibiting activity |
| 05/08/2007 | US7214802 Anti-cytokine heterocyclic compounds |
| 05/08/2007 | US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 05/08/2007 | US7214710 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 05/08/2007 | US7214698 Beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 05/08/2007 | US7214681 Tri(cyclo) substituted amide compounds |
| 05/08/2007 | US7214677 Benzamide, heteroarylamide and reverse amides |
| 05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 05/08/2007 | CA2386981C Preparation of 4-(4-fluorophenyl)-n-alkylnipecotinate esters, 4-(4-fluorophenyl)-n-arylnipecotinate esters and 4-(4-fluorophenyl)-n-aralkylnipecotinate esters |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2118564C Erythromycin derivatives, process for the preparation thereof and use thereof as medicaments |
| 05/03/2007 | WO2007049532A1 Aminodihydrothiazine derivative |
| 05/03/2007 | WO2007048788A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/03/2007 | WO2007048771A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | WO2007048643A1 Novel compound |
| 05/03/2007 | WO2007048361A1 A method of removing the triphenylmethane protecting group from precursors of antihypertensive drugs |
| 05/03/2007 | WO2007022947A3 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors |
| 05/03/2007 | WO2007011626A3 Histone deacetylase inhibitors |
| 05/03/2007 | WO2006111560A3 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
| 05/03/2007 | US20070100143 Crystalline alfuzosin base |
| 05/03/2007 | US20070100031 Ultraviolet light absorbers |
| 05/03/2007 | US20070099991 Selective rxr ligands |
| 05/03/2007 | US20070099960 Liver X receptors (LXR) modulators such as 1-[[4-(1,1-dimethylethyl)phenyl]sulfonyl]-4-methoxy-N-(2-phenyl ethyl)-2,3-dihydro-1H-)indole-2-carboxamide, used for the treatment of atherosclerosis, dyslipidemia, obesity, diabetes, hypercholesterolemia, neurodegenerative diseases and inflammatory diseases |
| 05/03/2007 | US20070099955 3-piperidinylisochroman-5-ols as dopamine agonists |
| 05/03/2007 | US20070099954 Prodrugs of compounds that inhibit TRPV1 receptor |
| 05/03/2007 | US20070099944 ROCK-1 kinase and/or Aurora kinase inhibitors; indazolo-tetrahydropyrimidine-carboxamide derivatives; 4-(4-fluorophenyl)-N-1H-indazol-5-yl-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxamide; antiinflammatory, antidiabetic, antiproliferative agents |
| 05/03/2007 | US20070099934 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b |
| 05/03/2007 | US20070099933 Indole derivatives as serotonin reuptake inhibitors |
| 05/03/2007 | US20070099924 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 05/03/2007 | US20070099922 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 05/03/2007 | US20070099908 Arylsulfonyl chromans as 5-HT6 inhibitors |
| 05/03/2007 | US20070099895 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 05/03/2007 | US20070099874 Methods and compositions of novel triazine compounds |
| 05/03/2007 | DE19522145B4 7,8-Difluortetralin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen 7,8-Difluortetralin derivatives and their use in liquid crystal mixtures |
| 05/03/2007 | DE10148618B4 Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel Substituted N- (1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their preparation and use as medicaments |
| 05/03/2007 | CA2628074A1 Aminodihydrothiazine derivative |
| 05/03/2007 | CA2627486A1 Novel indole-containing beta agonists, method for producing them and their use as drugs |
| 05/03/2007 | CA2626324A1 Arylurea derivatives as modulators of chemokine receptor activity |
| 05/03/2007 | CA2623879A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/02/2007 | EP1780211A2 Vanilloid receptor ligands and their use in treatments |
| 05/02/2007 | EP1780209A1 Oxime ester compound and photopolymerization initiator containing such compound |
| 05/02/2007 | EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1778678A1 Enantioselective process |
| 05/02/2007 | EP1778677A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 05/02/2007 | EP1778670A2 Medicinal use of receptor ligands |
| 05/02/2007 | EP1778669A2 Kinase inhibitors |
| 05/02/2007 | EP1778646A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 05/02/2007 | EP1778643A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 05/02/2007 | EP1778637A2 Fkbp binding composition and pharmaceutical use thereof |
| 05/02/2007 | EP1778634A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 05/02/2007 | EP1778233A1 Intracellular receptor modulator compounds and methods |
| 05/02/2007 | EP1458685B1 Substituted phenyl derivatives |
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1322608B1 Delta1-pyrrolines used as pesticides |
| 05/02/2007 | CN1956977A Pharmaceutical dosage forms and compositions of 5-HT1a receptor antagonists |
| 05/02/2007 | CN1956976A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956967A Novel amination process |
| 05/02/2007 | CN1956966A Quinazoline derivatives and therapeutic use thereof |
| 05/02/2007 | CN1956964A Tetrahydro-indazole cannabinoid modulators |
| 05/02/2007 | CN1956962A Tetrahydroisoquinoline sulfonamide derivatives, the preparation method thereof, and the use of the same in therapeutics |
| 05/02/2007 | CN1956959A Therapeutic compounds: pyridine N oxide scaffold |
| 05/02/2007 | CN1956955A Neurogenic pain control agent composition |
| 05/02/2007 | CN1956954A Novel androgens |
| 05/02/2007 | CN1956238A Luminescent element material and luminescent element comprising the same |
| 05/02/2007 | CN1956237A Luminescent element material and luminescent element comprising the same |
| 05/02/2007 | CN1955178A New benzimidazole derivative |
| 05/02/2007 | CN1955175A Cumarin derivative and its preparation method and its drug composite and use |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
| 05/02/2007 | CN1313463C Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them |
| 05/02/2007 | CN1313462C New 3-(4-oxygen-4H-benzopyranyl-2-base)-(1H)-quinoline-4-ketone derivant, its preparing method and drug compositions containing them |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313449C New quinazoline hind derivative, medicinal composition containing same and their use |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/01/2007 | USRE39606 Synthetic libraries of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer, for drug screening |
| 05/01/2007 | US7211672 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
| 05/01/2007 | US7211595 Substituted imidazoles and thiazoles |
| 05/01/2007 | US7211594 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 05/01/2007 | US7211570 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV") |